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The Impact of Warmed Intravenous
Contrast Material on the Bolus Geometry
of Coronary CT Angiography Applications
Objective: This study was designed to investigate the effect of administration
of warmed contrast material (CM) on the bolus geometry and enhancement as
depicted on coronary CT angiography.
Materials and Methods: A total of 64 patients (42 men, 22 women; mean age,
56 years) were randomly divided into two groups. Group 1 included 32 patients
administered CM (Omnipaque [Iohexol] 350 mg I/ mL; Nycomed, Princeton, NJ)
saline solutions kept in an incubator at a constant temperature (37℃). Group 2
included 32 patients administered the CM saline solutions kept at constant room
temperature (24℃). Cardiac CT scans were performed with a dual source com-
puted tomography (DSCT) scanner. For each group, region of interest curves
were plotted inside the ascending aorta, main pulmonary artery and descending
aorta on test bolus images. Using enhancement values, time/enhancement dia-
grams were produced for each vessel. On diagrams, basal Hounsfield unit (HU)
values were subtracted from sequentially obtained values. A value of 100 HU
was accepted as a cut-off value for the beginning of opacification. The time to
peak, the time required to reach 100 HU opacification, maximum enhancement
and duration of enhancement above 100 HU were noted. DSCT angiography
studies were evaluated for coronary vessel enhancement.
Results: Maximum enhancement values in the ascending aorta, descending
aorta and main pulmonary artery were significantly higher in group 1 subjects. In
the ascending aorta, the median time required to reach 100 HU opacification dur-
ing the test bolus analysis was significantly shorter for group 2 subjects than for
group 1 subjects. In the ascending aorta, the descending aorta and main pul-
monary artery, for group 1 subjects, the bolus geometry curve shifted to the left
and upwards as compared with the bolus geometry curve for group 2 subjects.
Conclusion: The use of warmed CM yields higher enhancement values and a
shorter time to reach maximum enhancement duration, resulting in a shift of the
bolus geometry curve to the left that may provide optimized image quality.
omputed tomography angiography (CTA) is a minimally invasive tool
utilized for the demonstration of vascular anatomy and related disorders
of several body regions (1). CTA enables fast scanning during the arterial
phase of contrast administration that provides maximum contrast between the artery
itself and its surroundings, particularly the venous structures (2). Contrast timing and
adequate enhancement is crucial for optimum image analysis and for a high quality
post-processing procedure, which necessitates sufficient arterial enhancement for
multidimensional (two-dimensional and three-dimensional) evaluation (2). In order to
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LAD = left anterior descending artery
LM = left main coronary artery
RCA = right coronary artery
ROI = region of interest
TME = time to maximum enhancement
Craphy, accurate timing of contrast bolus injection is vital.
Cademartiri et al. (2) based this issue on bolus geometry
that is defined as the pattern of enhancement in a region of
interest (ROI) drawn on a time/attenuation diagram.
Several studies have focused on accurate timing of contrast
bolus enhancement and geometry, and have focused on
factors that affect accurate timing of contrast bolus
enhancement and geometry (3-7). In this study, we have
investigated the effect of administration of warmed




Between January 2007 and February 2007, 64 consecu-
tive patients (42 men, 22 women; mean age, 56 years; age
range, 37-75 years) were enrolled in this study. All
patients were referred to our department for CTA evalua-
tion for possible coronary artery disease. Informed consent
was obtained from each patient. Inclusion criteria were as
follows: a minimum age of 18 years, absence of any
contraindication to intravenous CM and no history of
coronary artery stent and/or by-pass graft. Exclusion
criteria were a history of chronic renal failure and adverse
reactions to CM, pregnancy, a history of myocardial infarc-
tion and chronic heart failure.
Study Design
Local ethics committee approval was obtained before the
beginning of the study, and the study was designed in a
prospective randomized manner. A total of 64 patients
were randomly divided into two separate groups. In the
first group (group 1), warmed CM and saline was adminis-
tered while in the second group (group 2), normal CM and
saline were used. Group 1 consisted of 32 patients (23
men, 9 women; mean age, 59.9 ± 9.3 years; mean weight,
80.5 ± 13.6 kg; mean height, 169.8 ± 8.7 cm) while
group 2 consisted of 32 patients (19 men, 13 women; mean
age, 52 ± 10.4 years; mean weight, 79.4 ± 14.1 kg; mean
height, 170 ± 10.4 cm). Warmed CM and saline were kept
in a research-dedicated incubator at a continuously
monitored constant temperature of 37℃ for at least 12
hours. For group 2, CM and saline solutions were kept at
constant room temperature of 24℃ for at least 10 hours
before injection. The room temperature was kept constant
by the use of an air conditioning system. The staff technol-
ogists of the CT unit continuously monitored the room
temperature.
Image Acquisition
Cardiac CT scans were performed with a dual source CT
(DSCT) scanner (Somatom Definition; Siemens, Erlangen,
Germany). No beta-blocker was used in any of the
enrollees for regulation of the heart rate. After the acquisi-
tion of an initial scout image (120 kV, 36 mAs), the area
between the carina to the apex of the heart was scanned.
A test bolus technique was used before image acquisition
in each patient. Thirty non-incremental images of CT
sections were obtained at the level of the main pulmonary
artery with the following parameters: 120 kV, 45 mA, 0.75
sec scan time, 10 mm slice thickness. For test bolus scans,
20 ml of iodinated contrast agent (Omnipaque [Iohexol]
350 mg I/mL; Nycomed, Princeton, NJ) was administered
by an automated injector (Ulrich; Ulrich Medical, Ulm,
Germany) at a rate of 5 ml/sec via an 18-gauge needle
placed into the right antecubital vein. Following CM
administration, 20 ml of saline was administered at a flow
rate of 5 ml/sec through the same venous access. An ROI
was plotted inside the ascending aorta and a bolus
geometry curve was acquired. Curve diagrams were
analyzed immediately after acquisition, and the time to
maximum enhancement (TME) scan delay was measured
by adding up to 4 additional seconds to the TME value.
Image acquisition was performed when the patient
underwent a breath-hold. Iodinated contrast agent (80 ml)
was injected into the right antecubital vein via an 18-gauge
catheter with an injection rate of 5 ml/sec by the use of an
automated injector (Ulrich; Ulrich Medical) and 40 ml of
saline was infused following CM administration at the
same flow rate.
Dual source CT image acquisition parameters were as
follows: 0.75 mm slice thickness, tube voltage of 100 kV
for both tubes, 560 mA current with modulation and full
current between 30% and 80% of the cardiac cycle, gantry
rotation time of 0.330 sec and pitch 0.2-0.43 adapted to
the heart rate. Using a medium soft convolution kernel and
a mono-segment reconstruction algorithm that uses the
data from a quarter-rotation of both detectors, 1 mm axial
images were reconstructed for the entire cardiac cycle,
with reconstruction intervals in 10% steps. Computed
tomography images were transferred to a workstation
(Leonardo; Siemens, Germany) for post-processing and
final evaluation.
After image acquisition, each patient completed a survey
consisting of four questions. Every patient was questioned
regarding the severity of several subjective sensations of a
feeling of shivering, warmth and cold, as well as a feeling
of urgent void on a 5-point scale (1 = none, 2 = small, 3 =
tolerable, 4 = extensive, 5 = very extensive).
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For each group, test bolus image series and DSCT
angiography images were evaluated using the same
workstation. For analysis of the test bolus image series,
ROI curves of 3 cm
2 were placed on the center of the
ascending aorta, main pulmonary artery and descending
aorta, respectively. Enhancement values of each slice
(overall, 30 values) were noted separately in Hounsfield
units (HU). Using enhancement values, time/enhancement
diagrams were created for each of these three vessels in
every patient. On these diagrams, basal HU values
representing the initially acquired unenhanced HU value
were subtracted from the sequentially obtained HU values,
and finally, 100 HU was accepted as the cut-off (threshold)
value for the beginning of enhancement. After this
procedure, time to peak (the time required to reach the
maximum enhancement value from zero HU), time
required to reach 100 HU enhancement (threshold of
enhancement), maximum enhancement value (HU) and
duration of enhancement above 100 HU (plateau time)
were noted.
Reconstruction interval series (40%, 50%, 60% and
70%) of the DSCT coronary angiography studies were
evaluated. The most optimum interval for analysis by the
use of plotted ROI circle enhancement values of each
segment (proximal, middle, distal) of the right coronary
artery (RCA), left anterior descending artery (LAD),
circumflex coronary artery (CX) and left main coronary
artery (LM) were noted. Since the diameters of coronary
arteries varied because of dominancy, areas of the ROI
curves used for coronary arteries could not be kept
constant; however, in each artery, the entire luminal area
was covered. Using the evaluation software of the
workstation (In space, Leonardo; Siemens), the ejection
fraction (EF) of each patient was calculated to exclude
patients with an EF < 60%.
Statistical Analysis
Statistical analysis was carried out with the use of the
SPSS software package (SPSS, Chicago, IL). Data are
presented as means ± standard deviation. For the compar-
ison of the following parameters mean time to peak, time
required to reach peak enhancement, duration of enhance-
ment above 100 HU (plateau time) the Mann Whitney U
test was used.
For a comparison between the two groups regarding
demographic properties, EF, mean coronary artery
enhancement and maximum enhancement during test
bolus studies, the t-test was used. A p value of 0.05 was
considered as a threshold for a significant difference.
RESULTS
No significant differences were seen for demographic
factors such as sex, age, height and weight between the
two study groups. Mean heart rates during scans were 71
and 67 beats per minute for group 1 and group 2, respec-
tively, and there was no significant difference between the
two groups.
The mean EF values were 65 ± 4% and 66 ± 3.5% for
group 1 and group 2, respectively. No significant differ-
ence was noted between the two groups.
Coronary CT angiography was performed successfully in
64 patients and no major complications occurred. There
was no significant difference in the results of the survey
including the feeling of shivering, warmth and cold as well
as the feeling of the need for urgent void on a 5-point scale
between the two groups (Table 1).
In the ascending aorta, the mean maximum enhancement
values during test bolus analysis were 210 ± 25 HU and
178 ± 21 HU, for group 1 and group 2, respectively. In
the descending aorta, the mean maximum enhancement
values during test bolus analysis were 205 ± 22 HU and
174 ± 19 HU for group 1 and group 2, respectively. In the
main pulmonary artery, the mean maximum enhancement
values during test bolus analysis were 318 ± 30 HU and
283 ± 27 HU for group 1 and group 2, respectively. A
statistically significant difference between the two groups
for maximum enhancement values in the ascending aorta
and descending aorta and main pulmonary artery (p =
0.005) was detected.
In the ascending aorta, the mean duration of enhance-
ment above 100 HU (plateau time) during test bolus
analysis was 6.6 ± 1.51 sec and 5.9 ± 2.2 sec for group 1
and group 2, respectively. There was no significant differ-
ence between the two groups for the duration of enhance-
ment above 100 HU (plateau time) in the ascending aorta
(p = 0.187). In the descending aorta, the mean duration of
enhancement above 100 HU (plateau time) during test
bolus analysis was 6.7 ± 1.48 sec and 5.8 ± 2.11 sec for
group 1 and group 2, respectively. There was no statisti-
cally significant difference between the two groups for the
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Table 1. Results of Survey Completed by Patients of Two
Groups Based on Use of 5-point Scale*
Groups Shivering Warmth Cold Urgency to Void
Group 1 1.09 2.81 1 1.96
Group 2 1.09 3.21 1.18 2.03
Note.─ *1 = none, 2 = small, 3 = tolerable, 4 = extensive, 5 = very 
extensiveduration of enhancement above 100 HU (plateau time) in
the descending aorta (p = 0.063). In the main pulmonary
artery, the mean duration of enhancement above 100 HU
(plateau time) during test bolus analysis was 6.0 ± 1.25
sec and 5.3 ± 1.21 sec for group 1 and group 2, respec-
tively. No significant difference between the two groups
was detected for the duration of enhancement above 100
HU (plateau time) in the main pulmonary artery (p =
0.187).
The time to peak values during test bolus analysis was
found as 4.26 sec and 4.28 sec in the ascending aorta, 4.03
sec and 4.12 sec in the descending aorta and 5.16 sec and
5.20 sec in the main pulmonary artery for group 1 and
group 2, respectively. There was no statistically significant
difference between the two groups for the time to peak
values in the major vessels.
In the ascending aorta, the median time required to
reach the 100 HU enhancement value (threshold for
enhancement) during the test bolus analysis was 1.50 sec
and 2.25 sec for group 1 and group 2, respectively. A
statistically significant difference was detected between the
two groups for time required to reach the threshold
enhancement value in the ascending aorta (p = 0.034). In
the descending aorta, the median time required to reach
the threshold enhancement value during test bolus analysis
was 1.50 sec and 1.87 sec for group 1 and group 2, respec-
tively. There was no statistically significant difference
between the two groups for the time required to reach the
threshold enhancement value in the descending aorta (p =
0.305). In the main pulmonary artery, the median time
required to reach the threshold enhancement value during
test bolus analysis was 2.62 sec and 2.50 sec for group 1
and group 2, respectively. There was no significant differ-
ence between the two groups for the time required to
reach the threshold enhancement value in the main
pulmonary artery (Table 2).
Time/enhancement curves were constructed for the
ascending aorta and descending aorta and the main
pulmonary artery in both groups. In the ascending aorta
and descending aorta and the main pulmonary artery for
group 1, the bolus geometry curve shifted to the left and
upwards as compared with the bolus geometry curve for
group 2 (Fig. 1). There was no significant difference
between group 1 and group 2 for the mean enhancement
values of the coronary artery segments (Table 3).
DISCUSSION
Cademartiri et al. (2) defined optimal bolus geometry of
CT angiography as an immediate increase in enhancement
of the artery of interest to a maximum enhancement value
just before the initiation of a scan and reaching a steady
state interval in which enhancement does not change
during image acquisition. However, actual bolus geometry
differs from optimal geometry as following a steady
increase of enhancement, a steady decrease occurs in
actual bolus geometry and CT angiography images are
acquired during this up-slope and down-slope period (2).
Accurate timing of CM injection and an optimum start of
image acquisition is important to obtain images with
diagnostic quality (8). For this purpose, uniform and
prolonged enhancement of the artery of interest is
Warmed Intravenous Contrast Material on Bolus Geometry of Coronary CT Angiography
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Table 3. Mean Enhancement Values of Coronary Arteries in Both Groups
Coronary  Proximal  Middle  Distal  Proximal  Middle  Distal  Proximal  Middle  Distal 
Artery RCA RCA RCA
LM
LAD LAD LAD CX CX CX
Group 1 404 ± 59 386 ± 69 393 ± 74 398 ± 55 399 ± 54 352 ± 48 311 ± 54 399 ± 55 388 ± 52 356 ± 66
Group 2 392 ± 61 383 ± 61 381 ± 77 376 ± 66 382 ± 68 361 ± 63 299 ± 61 384 ± 62 376 ± 71 338 ± 70
Note.─ Data is presented as mean HU ± standard deviation. RCA = right coronary artery, LM = left main coronary artery, LAD = left anterior 
descending coronary artery, CX = circumflex coronary artery
Table 2. Test Bolus Analysis in Ascending Aorta, Descending Aorta and Main Pulmonary Artery for Group 1 and Group 2
Mean Maximum Time to Peak  Time to Reach  Plateau
Enhancement  Enhancement  Threshold (100 HU) Time 
Groups (HU) (sec) Enhancement (sec) (sec)
AA DA PA AA DA PA AA DA PA AA DA PA
Group 1 0.210 ± 25* 205 ± 22* 318 ± 30* 4.26 4.03 5.16 01.5* 01.5* 2.62 06.56 ± 1.51 6.67 ± 1.48* 00.6 ± 1.25
Group 2 177.7 ± 21* 174 ± 19* 283 ± 27* 4.28 4.12 5.20 2.25* 1.87* 02.5 5.83 ± 2.2 5.76 ± 2.11* 5.25 ± 1.21
Note.─ AA = ascending aorta, DA = descending aorta, PA = main pulmonary artery, HU = Hounsfield units, sec = seconds, * = statistically significant 
differenceimportant for image post-processing and final image
analysis, since those factors are highly dependent on the
contrast difference between vessels of interest and
background tissue (9).
Several studies had focused on various factors such as
patient demographics, cardiac functions, several diseases,
injection volume, injection rate, iodine concentration of the
CM, use of bolus chaser and prandial status and injection
site that affect actual bolus geometry (3, 4, 8, 10-16).
None of the studies has compared the effects of warmed
CM on bolus geometry. A study by Vergara and Seguel
(17) investigated the effects of warmed non-iodinated CM
on the prevalence of adverse reactions to CM. The investi-
gators determined that warming the CM to the level of
body temperature (35℃) before administration increased
patient compliance and tolerance. Cademartiri et al. (18)
used warmed CM in their study for the determination of
the effect of iodine concentration on vascular attenuation.
However, neither of these studies focused on the effect of
warming the CM on vascular enhancement and bolus
geometry.
Our results showed that warming CM to 37℃ led to an
increase of the peak enhancement value and shortening of
the time to reach the enhancement level of 100 HU in the
ascending aorta and descending aorta, respectively. A shift
of the bolus geometry curve towards the left in both the
ascending aorta and descending aorta was noted. Although
the plateau duration in the bolus geometry curve was not
found as statistically significant in the descending aorta, p
values of this analysis might represent a significance
tendency. The mean enhancement of all segments of the
coronary arteries (except for the middle segment of the
LAD) was found to be increased in the patient group that
had received warmed CM, but the difference between the
two groups was statistically insignificant probably due to
the relatively small patient population.
Knollmann et al. (19) concluded that the use of highly
concentrated iodinated contrast agent injected at high rates
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Fig. 1. Bolus geometry curves of ascending aorta (A) and descending aorta
(B) and main pulmonary artery (C) show shift of geometry curves towards
left in group 1 (with warmed contrast material); moreover, peak enhance-
ment values are higher in group 1 when compared to group 2 (with contrast
material kept at room temperature, 24℃).
Cdoes not increase iodine delivery to the vessel of interest
due to high viscosity. Halsell (20) proposed that heating
the CM is the most efficient method for the administration
of the high-viscosity CM through small-bore catheters.
When CM is warmed from 20℃ to 37℃, the viscosity
decreases nearly 50% (14.5/7.5) (18). Our results related
to bolus geometry parameters can be explained by the
lowered viscosity of the warmed CM.
We determined that the use of warmed CM provides
more enhancement and shortening of the time required to
reach the threshold enhancement value (100 HU), which
resulted in better visualization of the vessel of interest. The
lower viscosity of the warmed CM can explain these
results. This advantage may be exploited for various CT
angiography applications, but for coronary CT angiogra-
phy; since our results did not reveal a statistically signifi-
cant difference, the utility of the use of warmed CM
remains questionable, but further research with a larger
study group is required.
One limitation of this study is that results were obtained
from the test bolus analysis. However, test bolus analysis
results may not always reflect diagnostic CT angiography
examination results. In addition, bolus geometry curves
could not be obtained from diagnostic CT angiography
images. Another limitation is the automated injector
(Ulrich; Ulrich Medical, Ulm, Germany) that was used for
CM injection. The unit was a roller injector, unlike
commonly used barrel injectors in CT applications;
therefore, the results cannot be interpolated for the use of
other power injectors. Finally, we did not make a pressure
assessment of the power injector system, and possible
effects for changes in pressure were not included.
In conclusion, the use of warmed CM yielded better
enhancement and a shorter time required to reach the
threshold enhancement value that resulted in a shift of the
bolus geometry curve to the left. Although the use of
warmed CM may provide better image quality, further
large-scaled studies are still required in clinical applications
for the final analysis of CTA studies.
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